Lucentis Biosimilar FYB201/Ranivisio (ranibizumab) Approved In Brazil
Raniviso becomes first approved Lucentis biosimilar in Brazil Commercialization partnership established with Brazilian pharmaceutical company Biomm Product launch in Brazil expected in Q4 2025, kicking off the commercial rollout of FYB201 across Latin …